Literature DB >> 7556065

Telomere elongation in immortal human cells without detectable telomerase activity.

T M Bryan1, A Englezou, J Gupta, S Bacchetti, R R Reddel.   

Abstract

Immortalization of human cells is often associated with reactivation of telomerase, a ribonucleoprotein enzyme that adds TTAGGG repeats onto telomeres and compensates for their shortening. We examined whether telomerase activation is necessary for immortalization. All normal human fibroblasts tested were negative for telomerase activity. Thirteen out of 13 DNA tumor virus-transformed cell cultures were also negative in the pre-crisis (i.e. non-immortalized) stage. Of 35 immortalized cell lines, 20 had telomerase activity as expected, but 15 had no detectable telomerase. The 15 telomerase-negative immortalized cell lines all had very long and heterogeneous telomeres of up to 50 kb. Hybrids between telomerase-negative and telomerase-positive cells senesced. Two senescent hybrids demonstrated telomerase activity, indicating that activation of telomerase is not sufficient for immortalization. Some hybrid clones subsequently recommenced proliferation and became immortalized either with or without telomerase activity. Those without telomerase activity also had very long and heterogeneous telomeres. Taken together, these data suggest that the presence of lengthened or stabilized telomeres is necessary for immortalization, and that this may be achieved either by the reactivation of telomerase or by a novel and as yet unidentified mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556065      PMCID: PMC394507          DOI: 10.1002/j.1460-2075.1995.tb00098.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Structure and polymorphism of human telomere-associated DNA.

Authors:  W R Brown; P J MacKinnon; A Villasanté; N Spurr; V J Buckle; M J Dobson
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

Review 2.  Telomere loss: mitotic clock or genetic time bomb?

Authors:  C B Harley
Journal:  Mutat Res       Date:  1991 Mar-Nov       Impact factor: 2.433

Review 3.  Structure and function of telomeres.

Authors:  E H Blackburn
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

4.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.

Authors:  G B Morin
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

5.  Addition of telomere-associated HeT DNA sequences "heals" broken chromosome ends in Drosophila.

Authors:  H Biessmann; J M Mason; K Ferry; M d'Hulst; K Valgeirsdottir; K L Traverse; M L Pardue
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

6.  Telomere reduction in human colorectal carcinoma and with ageing.

Authors:  N D Hastie; M Dempster; M G Dunlop; A M Thompson; D K Green; R C Allshire
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

7.  A human bronchial epithelial cell strain with unusual in vitro growth potential which undergoes neoplastic transformation after SV40 T antigen gene transfection.

Authors:  R R Reddel; I C Hsu; M J Mass; B Hukku; B I Gerwin; S E Salghetti; A N Somers; A J Galati; W T Gunning; C C Harris
Journal:  Int J Cancer       Date:  1991-07-09       Impact factor: 7.396

8.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

9.  In vivo loss of telomeric repeats with age in humans.

Authors:  J Lindsey; N I McGill; L A Lindsey; D K Green; H J Cooke
Journal:  Mutat Res       Date:  1991-01       Impact factor: 2.433

10.  Structure and variability of human chromosome ends.

Authors:  T de Lange; L Shiue; R M Myers; D R Cox; S L Naylor; A M Killery; H E Varmus
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

View more
  361 in total

1.  Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA.

Authors:  H Niida; Y Shinkai; M P Hande; T Matsumoto; S Takehara; M Tachibana; M Oshimura; P M Lansdorp; Y Furuichi
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity.

Authors:  L M Colgin; C Wilkinson; A Englezou; A Kilian; M O Robinson; R R Reddel
Journal:  Neoplasia       Date:  2000 Sep-Oct       Impact factor: 5.715

3.  Telomerase activity is sufficient to allow transformed cells to escape from crisis.

Authors:  T L Halvorsen; G Leibowitz; F Levine
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

4.  A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation.

Authors:  Q X Li; J M Robbins; P J Welch; F Wong-Staal; J R Barber
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

5.  Activation of p53 protein by telomeric (TTAGGG)n repeats.

Authors:  M Milyavsky; A Mimran; S Senderovich; I Zurer; N Erez; I Shats; N Goldfinger; I Cohen; V Rotter
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

6.  Telomere, telomerase and digestive cancer.

Authors:  Javed Yakoob; Guo-Ling Hu; Xue-Gong Fan; Zheng Zhang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

7.  An alternative lifestyle for immortalized oral keratinocytes.

Authors:  R R Reddel
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

8.  Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.

Authors:  K Perrem; L M Colgin; A A Neumann; T R Yeager; R R Reddel
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

9.  Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining.

Authors:  Alan K Meeker; Wesley R Gage; Jessica L Hicks; Inpakala Simon; Jonathan R Coffman; Elizabeth A Platz; Gerrun E March; Angelo M De Marzo
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

10.  The yeast TEL1 gene partially substitutes for human ATM in suppressing hyperrecombination, radiation-induced apoptosis and telomere shortening in A-T cells.

Authors:  E Fritz; A A Friedl; R M Zwacka; F Eckardt-Schupp; M S Meyn
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.